Peru vs Trinidad and Tobago: HIV-positive TB patients on ART (antiretroviral therapy)
Peru
57.0%
in 2024
Trinidad and Tobago
51.0%
in 2024
Peru rank
137th
Trinidad and Tobago rank
139th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Peru
- Trinidad and Tobago
How they compare
Peru currently reports 57.0% against 51.0% in Trinidad and Tobago, a difference of 6.0%.
That makes Peru's figure about 1.1 times Trinidad and Tobago's.
The two have swapped places 7 times across 20 shared years of data; in 2003 it was Trinidad and Tobago ahead.
Peru ranks 137th and Trinidad and Tobago ranks 139th of 144 countries.
Across the 3 decades both report, Peru averaged higher in 1 and Trinidad and Tobago in 2.
Head to head by decade
| Decade | Peru | Trinidad and Tobago | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 17.7% | 43.7% | 26.0% | Trinidad and Tobago |
| 2010s | 60.8% | 42.7% | 18.1% | Peru |
| 2020s | 53.8% | 81.0% | 27.2% | Trinidad and Tobago |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Peru or Trinidad and Tobago?
- Peru, at 57.0% against 51.0% in Trinidad and Tobago as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Peru and Trinidad and Tobago?
- 6.0%, with Peru ahead.
- How many years of comparable data are there for Peru and Trinidad and Tobago?
- 20 years are reported by both, from 2003 to 2024.
- How do Peru and Trinidad and Tobago rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Peru ranks 137th and Trinidad and Tobago ranks 139th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.